| Model Number |
SXPP1A101 |
| Medical Device Problem Code |
Break (1069)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
03/18/2021
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Product complaint # (b)(4).The following information was requested, but unavailable: what was used to complete the procedure? no further information is available.Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.This is a combination product, and the event has been reviewed for both the suture and the triclosan.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Events reported via: (b)(4).Trade name - irgacare¿.Active ingredient(s): triclosan.Dosage form: suture/solid/parenteral.Strength: 2360 g/m.
|
| |
|
Event or Problem Description
|
|
It was reported that a patient underwent a total knee replacement procedure on (b)(6) 2021 and barbed suture was used.During the procedure, it was reported by a sales rep that suture breakage occurred 2 times in a row during continuous suturing on the subcutis.There were no adverse patient consequences reported.Additional information was requested.
|
| |
|
Additional Manufacturer Narrative
|
|
(b)(4).Date sent to the fda: 6/8/2021.This is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Trade name - irgacare®; active ingredient(s) ¿ triclosan; dosage form ¿ suture/solid/parenteral; strength ¿ = 2360 g/m.
|
| |
|
Search Alerts/Recalls
|